Iron homeostasis and anemia markers in early breast cancer - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Clinica Chimica Acta Année : 2014

Iron homeostasis and anemia markers in early breast cancer


Iron plays a fundamental role in cell life and its concentration in living organisms is precisely regulated. Different molecules for iron storage and transport are used to maintain its intracellular homeostasis which is often altered in cancer cells. Specifically, recent studies have demonstrated that in breast cancer cells, the expression/activity of several iron-related proteins, such as ferritin, hepcidin and ferroportin, is deregulated and that these alterations may have a prognostic impact in patients with breast cancer. Moreover, molecules that regulate iron metabolism could become therapeutic targets. This review focuses on recent findings on iron metabolism particularly in breast cancer and on the development of new biomarkers that may be used in the clinical routine for the diagnosis, prognosis and management of cancer-associated anemia as well as for monitoring personalized treatments.
Fichier non déposé

Dates et versions

hal-02181367 , version 1 (12-07-2019)



P. J. Lamy, A. Durigova, William Jacot. Iron homeostasis and anemia markers in early breast cancer. Clinica Chimica Acta, 2014, 434, pp.34--40. ⟨10.1016/j.cca.2014.04.011⟩. ⟨hal-02181367⟩
23 Consultations
0 Téléchargements



Gmail Facebook X LinkedIn More